IX Biopharma
42C----
Current ValuationThe current P/E ratio is -71.81, below the reasonable range, cheaper than 87.2% of the time in the past 5 years, and the industry ranks 6/6, the industry Median 13.42.
-71.81xP/E
S$0.53Stock price
S$-0.01Earnings per share
-71.81xP/E
Stock priceS$0.53Earnings per shareS$-0.01
Historical Valuation
P/E ratioTypical rangeMedian
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 13.42x
05101520
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 13.42x
0x4x8x12x16x20x
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.